Comorbidities and systemic effects of chronic obstructive pulmonary disease

Clin Chest Med. 2014 Mar;35(1):101-30. doi: 10.1016/j.ccm.2013.10.007.

Abstract

Although primarily a lung disease, chronic obstructive pulmonary disease (COPD) is now recognized to have extrapulmonary effects on distal organs, the so-called systemic effects and comorbidities of COPD. Skeletal muscle dysfunction, nutritional abnormalities including weight loss, cardiovascular complications, metabolic complications, and osteoporosis, among others, are all well-recognized associations in COPD. These extrapulmonary effects add to the burden of mortality and morbidity in COPD and therefore should be actively looked for, assessed, and treated.

Keywords: Chronic obstructive pulmonary disease; Comorbidities; Inflammation; Management strategy; Systemic effects.

Publication types

  • Review

MeSH terms

  • Anemia / etiology
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / prevention & control
  • Humans
  • Lung Neoplasms / etiology
  • Muscular Atrophy / etiology*
  • Muscular Atrophy / prevention & control
  • Osteoporosis / etiology
  • Osteoporosis / therapy
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Pulmonary Disease, Chronic Obstructive / psychology
  • Pulmonary Disease, Chronic Obstructive / therapy

Substances

  • Cardiovascular Agents